Organization
McMaster University, Hamilton, ON, Canada
9 abstracts
Abstract
The FARGO study: Frailty assessment for risk prediction in gynecologic oncology.Org: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON, Canada, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, Division of Gynecologic Oncology, Princess Margaret Cancer Centre/University Health Network/Sinai Health Systems, Toronto, ON, Canada, Trillium Health Partners - Credit Valley Hospital, Mississauga, ON, Canada, McMaster University, Hamilton, ON, Canada,
Abstract
canadian adalimumab post-marketing observational epidemiological study assessing the effectiveness of adalimumab vs non-biologic dmards in psoriatic arthritis (COMPLETE-PSA): 12-month effectiveness dataOrg: Memorial University of Newfoundland, St. John’s, Laval University, Centre Hospitalier de l’Université Laval, Quebec, University of Toronto, Toronto, ON, Canada, Centre Hhospitalier de l’Université de Montréal, Montreal, McMaster University, Hamilton, ON, Canada,
Abstract
ARE THERE GENDER SPECIFIC DIFFERENCES IN PATIENT REPORTED OUTCOMES AT INITIATION OF GOLIMUMAB TREATMENT IN RHEUMATOID ARTHRITIS? Org: University of Alberta, Edmonton, Canada, St Joseph's Hospital & McMaster University, Hamilton, Montreal General Hospital, Montreal, Centre de Rhumatologie de l'Est du Québec, Rimouski, University of Saskatchewan, Saskatoon,
Abstract
A RANDOMIZED DOUBLE BLIND PROOF OF CONCEPT TRIAL OF IMATINIB (GLEEVEC) IN ACTIVE DIFFUSE SCLERODERMA (DSSC) Org: Medicine, University of Western Ontario, Rheumatology, St. Joseph's Health Care, London, McMaster University, Hamilton, ON, Canada, Microbiology & Immunology, University of Western Ontario, London, Canada,
Abstract
ADDING ULTRASOUND TO THE TREAT-TO-TARGET STRATEGY SHOWS NO BENEFIT IN ACHIEVEMENT OF REMISSION: RESULTS FROM THE BIODAM COHORT Org: LUMC, Leiden, Netherlands, ARC, Amsterdam, Netherlands, Charité, Berlin, Germany, SVUH, Dublin, Ireland, McMaster University, Hamilton, ON, Canada,
Abstract
ASSESSING TREATMENT DURABILITY OF INFLIXIMAB IN THE MANAGEMENT OF PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITIS PATIENTS IN A CANADIAN SETTING Org: Mary Pack Arthritis Centre, Vancouver, University of Ottawa, Ottawa, Memorial University of Newfoundland, St. John's, Canada, University of Alberta, Edmonton, Canada, Montreal General Hospital, Montreal,
Abstract
A RANDOMIZED CONTROLLED TRIAL OF RHEUMATOLOGIST EDUCATION IMPACTING ON SYSTEMATIC MEASUREMENTS AND TREATMENT DECISIONS IN RHEUMATOID ARTHRITIS (RA): RESULTS OF THE METRIX STUDY Org: Rheumatology, St. Joseph's Health Care, London, Southlake Regional Health Centre, Newmarket, McMaster University, Hamilton, ON, Canada, Extension Marketing, Montreal, Canada,
Abstract
AN EVALUATION OF THE POTENTIAL EFFECTS OF A NATIONAL CONSENSUS STATEMENT ON OPTIMAL TREATMENT OF EARLY RHEUMATOID ARTHRITIS IN ONTARIO Org: McGill University, Montreal, QC, Canada, University of Toronto, Toronto, ON, Canada, McMaster University, Hamilton, ON, Canada, Institute for Clinical and Evaluative Sciences, Toronto, University of Western Ontarion, London,
Abstract
ASSOCIATION OF GASTROESOPHAGEAL FACTORS AND PROGRESSION OF INTERSTITIAL LUNG DISEASE IN THE CANADIAN SCLERODERMA RESEARCH GROUP (CSRG); A LARGE, MULTI-CENTER DATABASE Org: University of Western Ontario, London, ON, Canada, McMaster University, Hamilton, ON, Canada, Medicine, McGill, Montreal, Medicine, University of Western Ontario, London, Canada,